Acadia Healthcare ACHC Payments for (Proceeds from) Derivative Instrument, Investing Activities

Payments for (Proceeds from) Derivative Instrument, Investing Activities at other companies

ADTADT

-$460K-162%

Corebridge FinancialCRBG

$1.32B+62.5%

TIC Solutions TIC

$0-100%

ChemoursCC

$3M+50.0%

HQY

HealthEquityHQY

-$2.39M—

Equitable HoldingsEQH

-$180M+10.0%

Revenue$828.8M+7.6%

Net income$4.1M-51.0%

EPS (diluted)$0.05-44.4%

Cash & equivalents$158.5M+73.7%

Total debt$2.7B+14.7%

Total equity$2.0B-35.6%

Total assets$5.5B-9.8%

Operating cash flow$61.5M+436%

CapEx$76.6M-56.2%

Free cash flow-$15.0M+90.8%

Market cap$2.3B-23.6%

Net margin-32.8%-38.8pp

FCF margin-8.7%-0.1pp

Return on equity-44.3%-50.6pp

Debt / equity1.4×+0.6×

Current ratio1.7×+0.4×

Reported directly by Acadia Healthcare in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForProceedsFromDerivativeInstrumentInvestingActivities.

The official record: Acadia Healthcare’s 10-Q, filed May 4, 2022, on SEC EDGAR. View the filing →